Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 6/20 | 0.54 |
| ▸ | CA1 | P00915 | 5/20 | 0.54 |
| ▸ | ENPP2 | Q13822 | 5/20 | 0.54 |
| ▸ | LPL | P06858 | 2/20 | 0.42 |
| ▸ | LIPG | Q9Y5X9 | 2/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | CA4 | P22748 | 1/20 | 0.40 |
| ▸ | CA6 | P23280 | 1/20 | 0.40 |
| ▸ | CA5A | P35218 | 1/20 | 0.40 |
| ▸ | CA7 | P43166 | 1/20 | 0.40 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.40 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.40 |
| ▸ | MGLL | Q99685 | 2/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | F11 | P03951 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19214431 | 0.94 | CA2 (0.50) | CA2CA1ENPP2LPLLIPG | |
| SCHEMBL14355511 | 0.94 | CA2 (0.50) | CA2CA1ENPP2LPLLIPG | |
| SCHEMBL19214435 | 0.94 | CA2 (0.61) | CA2CA1ENPP2LPLLIPG | |
| SCHEMBL12045431 | 0.88 | CA2 (0.44) | CA2CA1ENPP2LPLLIPG | |
| SCHEMBL12045432 | 0.88 | CA2 (0.44) | CA2CA1ENPP2LPLLIPG | |
| SCHEMBL13018302 | 0.88 | CA2 (0.44) | CA2CA1ENPP2LPLLIPG | |
| SCHEMBL19214433 | 0.88 | ENPP2 (0.44) | CA2CA1ENPP2LPLLIPG | |
| SCHEMBL11887574 | 0.88 | LPL (0.50) | CA2CA1ENPP2LPLLIPG | |
| SCHEMBL14703502 | 0.88 | CA2 (0.44) | CA2CA1ENPP2LPLLIPG | |
| SCHEMBL12045433 | 0.88 | CA2 (0.45) | CA2CA1ENPP2LPLLIPG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11802170-B2 | Polyolefins prepared with binuclear metallocene catalysts | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2023-10-31 | — | — | US | disclosed |
| US-20230263058-A1 | ORGANIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT | CANON KABUSHIKI KAISHA (JP) | 2023-08-17 | — | — | US | disclosed |
| US-20230178848-A1 | ELECTRODE SEPARATORS | UNIV KING ABDULLAH SCI & TECH (SA) | 2023-06-08 | — | — | US | disclosed |
| US-11667835-B2 | Light-emitting composition | SUMITOMO CHEMICAL COMPANY LIMITED (JP) | 2023-06-06 | — | — | US | disclosed |
| US-11639937-B2 | Fluorescent methods and materials for directed biomarker signal amplification | SIRIGEN II LIMITED (GB) | 2023-05-02 | — | — | US | disclosed |
| US-9920093-B2 | Dimeric IAP inhibitors | TetraLogic Birinapant UK Ltd. (GB) | 2018-03-20 | — | — | US | disclosed |
| US-20180059117-A1 | FLUORESCENT METHODS AND MATERIALS FOR DIRECTED BIOMARKER SIGNAL AMPLIFICATION | SIRIGEN, INC. | 2018-03-01 | — | — | US | disclosed |
| US-20170226317-A1 | POLARIZING PLATE PROTECTIVE FILM, POLARIZING PLATE, AND DISPLAY DEVICE | FUJIFILM CORPORATION (JP) | 2017-08-10 | — | — | US | disclosed |
| US-20170115298-A1 | FLUORESCENT METHODS AND MATERIALS FOR DIRECTED BIOMARKER SIGNAL AMPLIFICATION | SIRIGEN II LIMITED (GB) | 2017-04-27 | — | — | US | disclosed |
| US-20170110517-A1 | PHOTOELECTRIC CONVERSION DEVICE AND IMAGING DEVICE | KABUSHIKI KAISHA TOSHIBA (JP) | 2017-04-20 | — | — | US | disclosed |
| US-8188121-B2 | Substituted pyridines as antiparasitic AZA teraryl compounds | THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) | 2012-05-29 | — | — | US | disclosed |
| US-20120029155-A1 | Fluorescent Methods and Materials for Directed Biomarker Signal Amplification | SIRIGEN INC. (US) | 2012-02-02 | — | — | US | disclosed |
| US-20120028828-A1 | Fluorescent Methods and Materials for Directed Biomarker Signal Amplification | SIRIGEN INC. (US) | 2012-02-02 | — | — | US | disclosed |
| US-20110301151-A1 | DIMERIC IAP INHIBITORS | TETRALOGIC PHARMACEUTICALS CORPORATION | 2011-12-08 | — | — | US | disclosed |
| US-20110257199-A1 | NOVEL TERARYL COMPOUNDS AS ANTIPARASITIC AGENTS | TIDWELL RICHARD R | 2011-10-20 | — | — | US | disclosed |
| US-20110198546-A1 | PHOTOCHROMIC MATERIAL | KOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION (KR) | 2011-08-18 | — | — | US | disclosed |
| US-20110064892-A1 | Polycyclic Organic Compounds, Retardation Layer and Compensation Panel on Their Base | CRYSOPTIX KK | 2011-03-17 | — | — | US | disclosed |
| US-20100087646-A1 | REAGENT FOR ORGANIC SYNTHESIS REACTION CONTAINING ORGANIC TRIOL BORATE SALT | WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) | 2010-04-08 | — | — | US | disclosed |
| US-7642361-B2 | Thiophene and furan compounds | ELI LILLY AND COMPANY (US) | 2010-01-05 | — | — | US | disclosed |
| US-20070105852-A1 | Thiophene and furan compounds | ELI LILLY AND COMPANY | 2007-05-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (10 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170110517-A1 | PHOTOELECTRIC CONVERSION DEVICE AND IMAGING DEVICE | TRRAP, CYP1A1, CYP1B1 | CA2 3853/4885CA1 3650/4885ENPP2 4725/4885 |
| US-11802170-B2 | Polyolefins prepared with binuclear metallocene catalysts | C1S, C9, C5 | CA2 3888/4885CA1 2072/4885ENPP2 2921/4885 |
| US-20110064892-A1 | Polycyclic Organic Compounds, Retardation Layer and Compensation Panel on Their Base | MCM3, CCNA2, CCNB2 | CA2 4322/4885CA1 3921/4885ENPP2 4111/4885 |
| US-20110301151-A1 | DIMERIC IAP INHIBITORS | BIRC2, XIAP, BIRC5 | CA2 1561/4885CA1 943/4885ENPP2 1885/4885 |
| US-20110257199-A1 | NOVEL TERARYL COMPOUNDS AS ANTIPARASITIC AGENTS | DDT, ZC3HAV1, MAVS | CA2 4533/4885CA1 4865/4885ENPP2 558/4885 |
| US-20100087646-A1 | REAGENT FOR ORGANIC SYNTHESIS REACTION CONTAINING ORGANIC TRIOL BORATE SALT | ORC3, OXSR1, OSTC | CA2 38/4885CA1 637/4885ENPP2 981/4885 |
| US-20170226317-A1 | POLARIZING PLATE PROTECTIVE FILM, POLARIZING PLATE, AND DISPLAY DEVICE | NBAS, SSB, BIRC5 | CA2 1171/4885CA1 1482/4885ENPP2 1144/4885 |
| US-20230263058-A1 | ORGANIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT | NR2E3, LGR4, NCOA4 | CA2 3559/4885CA1 3922/4885ENPP2 2364/4885 |
| US-20070105852-A1 | Thiophene and furan compounds | PSEN2, PSEN1, TPMT | CA2 4154/4885CA1 1384/4885ENPP2 3406/4885 |
| US-20110198546-A1 | PHOTOCHROMIC MATERIAL | PPOX, RAD51, DCLRE1A | CA2 3257/4885CA1 3911/4885ENPP2 3227/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.